Research Study

Past Study: BirdRock Bio

Study Status:  CLOSED

Study Name:  BIRDROCK BIO  

Study Focus:  Patients with Pre-Diabetes

Type II Diabetes W/ Fatty Liver

 

Study Contact: To learn more, please call 1-877-854-8475 or fill out the Contact us form.

Study Purpose:  To evaluate the safety and tolerability of an Investigational drug or placebo administered after 4 weeks of multiple IV dosing in patients with prediabetes or Type II diabetes  with Fatty Liver disease (NAFLD). 

To be enrolled in this study, you must meet certain requirements. You are eligible to participate if you meet the following criteria:

  • Pre-Diabetics or Type II Diabetics, men and women, with Fatty Liver (NAFLD)
  •  Ages 18 – 65

Study Duration:  up to 12 weeks

Study Commitment:

  • 2 Screening visit
  • Total of 7 Overnight Stays
  • Total of 8 Outpatient Visits
  • Study drug or placebo infusions for 30 minutes once per week for 4 weeks

Study Procedures:

  • Physical exam, vital signs, height, and weight, EKG
  • IV insertion
  • Multiple blood draws
  • FibroScan
  • OGTT
  • DNL Procedure
  • MRI
  • Urine Drug Screen
  • Pregnancy Test
  • Dietary Counseling

Compensation offered up to $ 4725.00

This study is being conducted under the direction of Dr. Steven Smith, at 301 East Princeton Street Orlando, Florida 32804